Literature DB >> 18037937

Stem cell-derived cardiomyocytes after bone marrow and heart transplantation.

R A de Weger1, I Verbrugge, A H Bruggink, M M van Oosterhout, Y de Souza, D F van Wichen, F H J Gmelig-Meyling, N de Jonge, L F Verdonck.   

Abstract

Cardiomyocytes are a stable cell population with only limited potential for renewal after injury. Tissue regeneration may be due to infiltration of stem cells, which differentiate into cardiomyocytes. We have analysed the influx of stem cells in the heart of patients who received either a gender-mismatched BMT (male donor to female recipient) or a gender-mismatched cardiac transplant (HTX; female donor to male recipient). The proportion of infiltrating cells was determined by Y-chromosome in situ hybridization combined with immunohistochemical cell characterization. In BM transplanted patients and in cardiac allotransplant recipients, cardiomyocytes of apparent BM origin were detected. The proportions were similar in both groups and amounted up to 1% of all cardiomyocytes. The number of stem cell-derived cardiomyocytes did not alter significantly in time, but were relatively high in cases where large numbers of BM-derived Y-chromosome-positive infiltrating inflammatory cells were present. The number of Y-chromosome-positive endothelial cells was small and present only in small blood vessels. The number of BM-derived cardiomyocytes in both BMT and HTX is not significantly different between the two types of transplantation and is at most 1%.

Entities:  

Mesh:

Year:  2007        PMID: 18037937     DOI: 10.1038/sj.bmt.1705939

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  9 in total

Review 1.  Lysophospholipids in coronary artery and chronic ischemic heart disease.

Authors:  Ahmed Abdel-Latif; Paula M Heron; Andrew J Morris; Susan S Smyth
Journal:  Curr Opin Lipidol       Date:  2015-10       Impact factor: 4.776

2.  Evidence of mobilization of pluripotent stem cells into peripheral blood of patients with myocardial ischemia.

Authors:  Ahmed Abdel-Latif; Ewa K Zuba-Surma; Khaled M Ziada; Magdalena Kucia; Donald A Cohen; Alan M Kaplan; Gary Van Zant; Samy Selim; Susan S Smyth; Mariusz Z Ratajczak
Journal:  Exp Hematol       Date:  2010-08-26       Impact factor: 3.084

3.  Microchimerism in salivary glands after blood- and marrow-derived stem cell transplantation.

Authors:  Simon D Tran; Robert S Redman; A John Barrett; Steven Z Pavletic; Sharon Key; Younan Liu; Ashley Carpenter; Hieu M Nguyen; Yoshinori Sumita; Bruce J Baum; Stanley R Pillemer; Eva Mezey
Journal:  Biol Blood Marrow Transplant       Date:  2010-12-04       Impact factor: 5.742

4.  Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction.

Authors:  Anush V Karapetyan; Yuri M Klyachkin; Samy Selim; Manjula Sunkara; Khaled M Ziada; Donald A Cohen; Ewa K Zuba-Surma; Janina Ratajczak; Susan S Smyth; Mariusz Z Ratajczak; Andrew J Morris; Ahmed Abdel-Latif
Journal:  Stem Cells Dev       Date:  2013-02-19       Impact factor: 3.272

Review 5.  A novel role for bioactive lipids in stem cell mobilization during cardiac ischemia: new paradigms in thrombosis: novel mediators and biomarkers.

Authors:  Prabhakara R Nagareddy; Ahmed Asfour; Yuri M Klyachkin; Ahmed Abdel-Latif
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

Review 6.  Cardiac allograft vasculopathy: a donor or recipient induced pathology?

Authors:  Patricia van den Hoogen; Manon M H Huibers; Joost P G Sluijter; Roel A de Weger
Journal:  J Cardiovasc Transl Res       Date:  2015-02-05       Impact factor: 4.132

Review 7.  The role of bioactive lipids in stem cell mobilization and homing: novel therapeutics for myocardial ischemia.

Authors:  Yuri M Klyachkin; Anush V Karapetyan; Mariusz Z Ratajczak; Ahmed Abdel-Latif
Journal:  Biomed Res Int       Date:  2014-01-06       Impact factor: 3.411

8.  Bone marrow SSEA1+ cells support the myocardium in cardiac pressure overload.

Authors:  Amanda Finan; Nikolai Sopko; Feng Dong; Ben Turturice; Matthew Kiedrowski; Marc S Penn
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

Review 9.  Stem Cells in Cardiovascular Diseases: 30,000-Foot View.

Authors:  Thomas J Povsic; Bernard J Gersh
Journal:  Cells       Date:  2021-03-09       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.